Donafenib combined with transarterial chemoembolization(TACE)and camrelizumab as conversion therapy for initial unresectable hepatocellular carcinoma(HCC):a prospective,single-arm,single center,phase Ⅱ clinical studyCAO Yajuan, ZHANG Xuebin, SHI Jiong, TANG Min, CHENG Chunxiao, YU Decai481-487
Bioinformatics analysis and clinical validation of miR-16-5p in breast cancerHUANG Liang, GAO Dong, ZHOU Dandan, CHEN Fanghong488-494
Expression and clinical significance of KDF1 in epithelial ovarian cancerZENG Shangyun, LU Ye, AN Xiaoyan495-501
Expression of serum ZFPL1 protein in prostate cancer and its clinical significanceHU Jinshan, GAO Jinding, LIU Yu502-507
Expression and clinical significance of serum sMICA,microRNA-99a and DJ-1 in non-small cell lung cancerLU Fang, QIAN Wenxia, XUAN Xiaofeng508-512
Expression and clinical significance of miRNA-1290 in serum of patients with esophageal cancerXU Guangyuan, WANG Yichun, ZHANG Yuning513-516
Expression and clinical significance of miR-337-3p,miR-484,miR-582 in serum of osteosarcomaZHANG Tiandan, HUYong, HUNAG Shiyue, XU Gang, HAO Peng, PANG Jian, LIU Feiwen517-523
Expression and clinical significance of miR-221/miR-222 and c-KIT in gastrointestinal stromal tumorsLI Yun, ZHOU Guangting, WANG Gang, LU Feng, YANG Haiyan524-529
Status and clinical significance of HOXD10 methylation in endometrial carcinomaWANG Chenhui, YU Ting, CHEN Liyan, WANG Xiuying530-536
Clinical observation of total laparoscopic modified anastomosis for radical resection of left colon cancerDENG Xianrui, ZHENG Lei, YANG Chun, SONG Yinghan537-540
